Menu
Back to User profile » Dr Mei Sheng Duh
Papers published by Dr Mei Sheng Duh:
Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R
Journal of Asthma and Allergy 2023, 16:1309-1322
Published Date: 1 December 2023
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
Bogart M, Germain G, Laliberté F, Lejeune D, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1575-1586
Published Date: 24 July 2023
Profiling Disease and Economic Burden in CRSwNP Using Machine Learning
Bhattacharyya N, Silver J, Bogart M, Kponee-Shovein K, Cheng WY, Cheng M, Cheung HC, Duh MS, Hahn B
Journal of Asthma and Allergy 2022, 15:1401-1412
Published Date: 30 September 2022
Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Kunzweiler C, Vu JD, Cheung HC, Duh MS
ClinicoEconomics and Outcomes Research 2022, 14:357-369
Published Date: 3 May 2022
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
Mannino D, Bogart M, Germain G, Huang SP, Ismaila AS, Laliberté F, Jung Y, MacKnight SD, Stiegler MA, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:491-504
Published Date: 5 March 2022
Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Mapel DW, Roberts MH, Sama S, Bobbili PJ, Cheng WY, Duh MS, Nguyen C, Thompson-Leduc P, Van Dyke MK, Rothnie KJ, Sundaresan D, Certa JM, Whiting TS, Brown JL, Roblin DW
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1687-1698
Published Date: 9 June 2021
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1149-1161
Published Date: 22 April 2021
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA
Cancer Management and Research 2020, 12:9713-9719
Published Date: 7 October 2020
Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study
Morse MA, Liu E, Joish VN, Huynh L, Cheng M, Duh MS, Seth K, Lapuerta P, Metz DC
Cancer Management and Research 2020, 12:6607-6614
Published Date: 30 July 2020
Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
Pepose JS, Sarda SP, Cheng WY, McCormick N, Cheung HC, Bobbili P, Joseph C, Duh MS
Clinical Ophthalmology 2020, 14:377-387
Published Date: 11 February 2020
Characterizing Real-World Use Of Tiotropium In Asthma In The USA
Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S
Journal of Asthma and Allergy 2019, 12:309-321
Published Date: 7 October 2019
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:343-352
Published Date: 19 February 2019
Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2859-2868
Published Date: 12 September 2018
Burden of disease associated with a COPD eosinophilic phenotype
Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2425-2433
Published Date: 13 August 2018
Removal of ineligible outcome cases reduces confounding
Walker AM, Schneeweiss S, DerSarkissian M, Duh MS
Clinical Epidemiology 2018, 10:575-579
Published Date: 21 May 2018
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1825-1836
Published Date: 21 June 2017